Drawing for HBI

USPTO serial 79054206

HBI

Reviewed by CopyMark Law Group

Status 404
Filing date
Status date
Registration date
—
Examiner
FRENCH, CURTIS W
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HBI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Howard N. Aronson

Howard N. Aronson Lackenbach Siegel LLPOne Chase RoadLackenbach Siegel BuildingScarsdale, NY 10583

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for use in treating viral and bacterial infections, oral care, cold sores, influenza, cancer, AIDS-related infections and bodily conditions associated with impaired immune systems, single gene disorders, blood disorders, vascular disorders, diseases of the central nervous system, cardiac disorders, inflammatory and auto-immune diseases; sanitary preparations for medical use; fruit extracts adapted for medical use in treating influenza and diseases of the respiratory system; chemical preparations for pharmaceutical purposes for use in treating viral and bacterial infections, oral care, cold sores, influenza, cancer, AIDS-related infections and bodily conditions associated with impaired immune systems, single gene disorders, blood disorders, vascular disorders, diseases of the central nervous system, cardiac disorders, inflammatory and auto-immune diseases; diagnostic preparations for medical use, all for in vivo use; micro-organisms and preparations of micro-organisms for use in treating viral and bacterial infections, oral care, cold sores, influenza, cancer, AIDS-related infections and bodily conditions associated with impaired immune systems, single gene disorders, blood disorders, vascular disorders, diseases of the central nervous system, cardiac disorders, inflammatory and auto-immune diseases; mineral salts for medical use; medicated candy, medicated throat lozenges, enzyme preparations for use in treating viral and bacterial infections, oral care, cold sores, influenza, cancer, AIDS-related infections and bodily conditions associated with impaired immune systems, single gene disorders, blood disorders, vascular disorders, diseases of the central nervous system, cardiac disorders, inflammatory and auto-immune diseasesACTIVE—
010Surgical, medical and dental apparatus and instruments, namely, injection needles, syringes for medical purposes and for injections; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic supports, orthopedic braces, plaster casts for orthopedic purposes, orthopedic support bandages, elastic bandages, slings; suture materialsACTIVE—
035The bringing together for the benefit of others, of a variety of healthcare goods enabling customers to conveniently view and purchase those goods and services from an Internet web site particularly specializing in the marketing of the sale of goods and services of others; business management services relating to retail of healthcare products, beauty products, toiletry products, food products, beverages, medicines and pharmaceutical products; mail order services featuring healthcare products; online retail stores featuring healthcare products; retail pharmacy servicesACTIVE—
044Medical treatment services, medical diagnostic services, medical prophylactic services; medical advice and information servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2009DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 22, 2009MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Apr 22, 2009ABN1ABANDONMENT - EXPRESS MAILED—
Apr 21, 2009EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Feb 5, 2009GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 5, 2009GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 5, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 13, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 13, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 15, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 15, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 8, 2008RFNPREFUSAL PROCESSED BY IB—
Jul 14, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 14, 2008RFRRREFUSAL PROCESSED BY MPU—
Jul 12, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 11, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2008DOCKASSIGNED TO EXAMINER—
Jul 7, 2008NWAPNEW APPLICATION ENTERED—
Jul 3, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance